Clinical Trials in Pittsburgh

Showing 9981-10000 of 16,007 trials

Novel Mobile Device Application to Improve Adherence

NCT02904278

The purpose of this study is to collect and compare information on how and when adolescent heart transplant recipients take their prescribed medication. The investigators want to find out if regular use of 'an app' on cell phones, called the Teen Pocket PATH® (TPP), can help adolescents take their medication according to their prescribed dosing schedule. This may then help reduce complications of transplant, such as rejection. The investigators also want to find out if how adolescent heart transplant recipients take their medications affects the development of antibodies in their blood. Antibodies are small proteins in the blood that may develop after heart transplantation, and which can sometimes damage a new heart.

Pediatric Heart Transplant RecipientsPediatric Cardiac TransplantationPediatric Heart Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)26 participantsStarted Aug 2017

Atlanta, Georgia, United States • Boston, Massachusetts, United States • St Louis, Missouri, United States +5 more locations

COMPLETEDNA< 1 mile

ImageReady(TM) MR Conditional Pacing System Clinical Study

NCT01781078

The objective of the SAMURAI Clinical Study is to collect data to confirm the safety, performance and effectiveness of the ImageReady System for use in the Magnetic Resonance Imaging (MRI) environment when used in accordance with the Conditions of Use included in the Boston Scientific MRI Technical Guide

BradycardiaSinus Node Dysfunction

Boston Scientific Corporation363 participantsStarted Feb 2013

Mesa, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +38 more locations

Novel Mobile Device Application to Improve Adherence

ImageReady(TM) MR Conditional Pacing System Clinical Study

Find Trials by Condition in Pittsburgh

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

HW006 LATERAL Thoracotomy

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

Post Market Surveillance Study of the Wingspan Stent System

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

A Clinical Trial of IntensiVE Dialysis

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency

Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria

Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

PF-06741086 Multiple Dose Study in Severe Hemophilia

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis